Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Distributor Of Genway In India"

06:57 EDT 20th April 2014 | BioPortfolio

Original Source: GenWay Biotech, Inc

As a leading protein and antibody solutions provider, GenWay has a proprietary technology platform and an international network to provide our clients with solutions and applications for antibodies, recombinant proteins, full-length cDNAs, cell lines and tissue samples. We specialize in recombinant proteins and domain-specific IgY (chicken) antibodies and their applications. GenWay’s technology and expertise make high quality protein antigens that enable production of high quality antibodies. To date,...

Matching Channels

India

India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps...

India ink colloidal carbon stain

Matching News

Mobile Commerce Market in India 2012-2016 Features Giants Axis Bank Ltd., Vodafone India and PayMate India Pvt. Ltd.

Dublin, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/rzlttr/mobile_commerce) has announced the addition of the "Mobile Commerce Mar...

Roche Sues India Drug Regulator, Two Firms For Fate Of Its Herceptin

Roche's India subsidiary has filed a suit in India not only against two drug makers, Biocon and Mylan, but also the Drug Controller General of India over the launch of the first biosimilar of its Herc...

Chief India Drug Regulator Says Few India Maker Meets Global Standards

The Drug Controller General of India suggested in an interview that no India drug maker meets global standards, which that if strictly applied in India would lead to nearly all of the makers being clo...

Chief India Drug Regulator Says Few India Makers Meets Global Standards

The Drug Controller General of India suggested in an interview that no India drug maker meets global standards, which if strictly applied in India would lead to nearly all of the makers being closed.

Premium-priced Tresiba starts on strong note in India?

While an out-of-pocket market like India may not be strictly comparable with reimbursed markets like the UK and it's not immediately clear how much of the India pricing is related to the depreciation...

Hypertension skyrocketing in India

Hypertension is skyrocketing in India, with rural-to-urban migrants at especially high risk. Hypertension will be a key theme at the 65th Annual Conference of the Cardiological Society of India, which...

Mylan debuts Hertraz, first Herceptin biosimilar, in India

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product, developed with India’s Biocon and cleared by the Drug Controller General of India last fall (The...

Emerging Markets Regulatory Tracker: India, Turkey (Vol. 4 No. 4)

India Commerce Secretary claims India drugs are unfairly targeted. Turkey issues new standards for medical devices.

Matching PubMed Articles

"I pick you": the impact of fairness and race on infants' selection of social partners.

By 15 months of age infants are sensitive to violations of fairness norms as assessed via their enhanced visual attention to unfair versus fair outcomes in violation-of-expectation paradigms. The curr...

Exploratory Qualitative Study for Community Management and Control of Tuberculosis in India.

Tuberculosis (TB) is a major public health problem in India which accounts for nearly one-fifth of the global TB burden. Though India has been gaining success in eliminating TB, the disease still kill...

Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India.

Cervical cancer is the leading cause of cancer mortality among women in India. Because Pap smear screening is not feasible in India, we need to develop effective alternatives.

Why are clinical trials necessary in India?

Clinical trials are emerging as an important activity in India as it is an essential component of the drug discovery and development program to which India is committed. The only robust way to evaluat...

Associations between Extreme Precipitation and Gastrointestinal-Related Hospital Admissions in Chennai, India.

Understanding the potential links between extreme weather events and human health in India is important in the context of vulnerability and adaptation to climate change. Research exploring such linkag...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement